
    
      The trial includes two parts and here is part II. This part is a multi-center, prospective,
      registration study which focuses on the treatment of below-knee arterial lesion. Totally 130
      patients will be entered into this part. They should suffer ischemic symptom with Rutherford
      3-6 for the occlusion of the below-knee arteries(anterior tibial„ÄÅposterior tibial or peroneal
      artery). According to the lesion length, the patients will accept transluminal angioplasty or
      below-knee arterial bypass. They will be followed up for 3 years. Study examinations will be
      done at screening, procedure time, 1, 6, 12, 24 and 36 months after procedure.
    
  